SENORES PHARMACEUTICALS
Back to Cashflow Statement
|
SENORES PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-1.33 Cr | ₹573 Cr | ₹87 Cr | ₹46 Cr | ₹36 Cr |
What is the latest Cash Flow from Financing Activities ratio of SENORES PHARMACEUTICALS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹-1.33 Cr |
| Mar2025 | ₹573 Cr |
| Mar2024 | ₹87 Cr |
| Mar2023 | ₹46 Cr |
| Mar2022 | ₹36 Cr |
How is Cash Flow from Financing Activities of SENORES PHARMACEUTICALS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-1.33 Cr | Negative | |
| Mar2025 | ₹573 Cr | 558.92 | |
| Mar2024 | ₹87 Cr | 88.06 | |
| Mar2023 | ₹46 Cr | 26.84 | |
| Mar2022 | ₹36 Cr | - | |
Compare Cash Flow from Financing Activities of peers of SENORES PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SENORES PHARMACEUTICALS | ₹5,420.9 Cr | 4.3% | -9.8% | 49.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹457,073.0 Cr | 8.1% | 9.3% | 9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹307,147.0 Cr | 10.5% | 18% | 51.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,626.0 Cr | 2.9% | 2.1% | 30.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,685.0 Cr | -0.1% | 16% | 14.6% | Stock Analytics | |
| CIPLA | ₹113,589.0 Cr | 1.4% | 8.1% | -6.8% | Stock Analytics | |
SENORES PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SENORES PHARMACEUTICALS | 4.3% |
-9.8% |
49.7% |
| SENSEX | 5.5% |
13.3% |
-3.4% |
You may also like the below Video Courses